Primary Objective:

To demonstrate the absence of photoirritation and potential photosensitization of the product Dermacyd PHDESILSTYFR.

Inclusion criteria:

• Phototype Skin II and III Integral skin test in the region
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion

Exclusion criteria:

• Lactation or pregnancy
• Use of Antiinflammatory 30 days and/or immunossupression drugs until 3 months before volunteers selection
• Disease which can cause immunosuppresion, such as diabetes, HIV
• Concomitant use of photosensitivity drugs
• History of sensitivity or photosensitivity with topic products
• Cutaneous active disease which can modify the study results
• History or activity of photodermatosis
• Personal or family antecedents of cutaneous neoplasia photo induced
• Presence of injury precursor of cutaneous neoplasia, such as melanociticos nevus and actinic keratosis
• Intense exposure solar in the test region
• Use of new drugs and/or cosmetics during the study
• Previous participation in studies using the same product in test
• Relevant history or confirmation of alcohol or other drugs abuse
• Intolerance detected or suspected for some component of the sample tested
• Medecin or sponsor employees or their close family.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.